-
1
-
-
0029111498
-
Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
-
Aceto MD, Scates SM, Lowe JA, Martin BR (1995) Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur J Pharmacol 282:R1-R2
-
(1995)
Eur J Pharmacol
, vol.282
-
-
Aceto, M.D.1
Scates, S.M.2
Lowe, J.A.3
Martin, B.R.4
-
3
-
-
0030738512
-
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
-
Arnone M, Maruani J, Chaperon F, Thiébot MH, Poncelet M, Soubrié P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132:104-106
-
(1997)
Psychopharmacology
, vol.132
, pp. 104-106
-
-
Arnone, M.1
Maruani, J.2
Chaperon, F.3
Thiébot, M.H.4
Poncelet, M.5
Soubrié, P.6
Le Fur, G.7
-
4
-
-
0015795117
-
The experimental reproduction of amphetamine psychosis
-
Bell DS (1973) The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29:35
-
(1973)
Arch Gen Psychiatry
, vol.29
, pp. 35
-
-
Bell, D.S.1
-
5
-
-
0031780582
-
Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats
-
Chaperon F, Soubrié P, Puech AJ, Thiébot MH (1998) Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology 135:324-332
-
(1998)
Psychopharmacology
, vol.135
, pp. 324-332
-
-
Chaperon, F.1
Soubrié, P.2
Puech, A.J.3
Thiébot, M.H.4
-
6
-
-
0020559420
-
L-Dopa and piribedil alter different components of attentional behaviour dependent on dose
-
Cheal ML (1983) L-Dopa and piribedil alter different components of attentional behaviour dependent on dose. Psychopharmacology 80:345-350
-
(1983)
Psychopharmacology
, vol.80
, pp. 345-350
-
-
Cheal, M.L.1
-
7
-
-
0029084341
-
Prevention by cannabinoid antagonist SR 141716A of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice
-
Collins DR, Pertwee RG, Davies SN (1995) Prevention by cannabinoid antagonist SR 141716A of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol 115:869-870
-
(1995)
Br J Pharmacol
, vol.115
, pp. 869-870
-
-
Collins, D.R.1
Pertwee, R.G.2
Davies, S.N.3
-
8
-
-
0027078685
-
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
-
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LS, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
-
(1992)
Science
, vol.258
, pp. 1946-1949
-
-
Devane, W.A.1
Hanus, L.2
Breuer, A.3
Pertwee, R.G.4
Stevenson, L.S.5
Griffin, G.6
Gibson, D.7
Mandelbaum, A.8
Etinger, A.9
Mechoulam, R.10
-
9
-
-
0030601692
-
Prepulse inhibition and latent inhibition: The role of dopamine in the medial prefrontal cortex
-
Ellenbroek BA, Budde S, Cools AR (1996) Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 75:535-542
-
(1996)
Neuroscience
, vol.75
, pp. 535-542
-
-
Ellenbroek, B.A.1
Budde, S.2
Cools, A.R.3
-
10
-
-
0030972351
-
Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system
-
Emrich HM, Markus Leweke F, Schneider U (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56:803-807
-
(1997)
Pharmacol Biochem Behav
, vol.56
, pp. 803-807
-
-
Emrich, H.M.1
Markus Leweke, F.2
Schneider, U.3
-
11
-
-
0030980893
-
Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A
-
Gessa GL, Mascia MS, Casu MA, Carta G (1997) Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Eur J Pharmacol 327:R1-2
-
(1997)
Eur J Pharmacol
, vol.327
-
-
Gessa, G.L.1
Mascia, M.S.2
Casu, M.A.3
Carta, G.4
-
12
-
-
0032472382
-
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
-
Gessa GL, Melis M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39-44
-
(1998)
Eur J Pharmacol
, vol.341
, pp. 39-44
-
-
Gessa, G.L.1
Melis, M.2
Muntoni, A.L.3
Diana, M.4
-
13
-
-
0028308591
-
Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: Implications for animal models of schizophrenic attentional dysfunction
-
Killcross AS, Dickinson A, Robbins TW (1994) Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology 115:185-195
-
(1994)
Psychopharmacology
, vol.115
, pp. 185-195
-
-
Killcross, A.S.1
Dickinson, A.2
Robbins, T.W.3
-
14
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
-
Matsuda LA, Lolait SJ, Brownstein MJ, Young AL, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
-
(1990)
Nature
, vol.346
, pp. 561-564
-
-
Matsuda, L.A.1
Lolait, S.J.2
Brownstein, M.J.3
Young, A.L.4
Bonner, T.I.5
-
16
-
-
0029012014
-
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
-
Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90
-
(1995)
Biochem Pharmacol
, vol.50
, pp. 83-90
-
-
Mechoulam, R.1
Ben-Shabat, S.2
Hanus, L.3
Ligumsky, M.4
Kaminski, N.E.5
Schatz, A.R.6
Gopher, A.7
Almog, S.8
Martin, B.R.9
Compton, D.R.10
Pertwee, R.G.11
Griffin, G.12
Bayewitch, M.13
Barg, J.14
Vogel, Z.15
-
17
-
-
0024348991
-
Which atypical antipsychotics are identified by screening tests?
-
Moore NC, Gershon S (1989) Which atypical antipsychotics are identified by screening tests? Clin Neuropharmacol 12:167-184
-
(1989)
Clin Neuropharmacol
, vol.12
, pp. 167-184
-
-
Moore, N.C.1
Gershon, S.2
-
18
-
-
0027515373
-
Molecular characterization of a peripheral receptor for cannabinoids
-
Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65
-
(1993)
Nature
, vol.365
, pp. 61-65
-
-
Munro, S.1
Thomas, K.L.2
Abu-Shaar, M.3
-
20
-
-
0030609879
-
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat
-
Navarro M, Hernandez E, Muñoz RM, delArco I, Villanúa MA, Carrera MRA, deFonseca FR (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8:491-496
-
(1997)
Neuroreport
, vol.8
, pp. 491-496
-
-
Navarro, M.1
Hernandez, E.2
Muñoz, R.M.3
DelArco, I.4
Villanúa, M.A.5
Carrera, M.R.A.6
DeFonseca, F.R.7
-
21
-
-
0017397124
-
Differences in locomotor activity between rats and gerbils in response to novelty
-
Osborne GL (1977) Differences in locomotor activity between rats and gerbils in response to novelty. Behav Biol 19:548-553
-
(1977)
Behav Biol
, vol.19
, pp. 548-553
-
-
Osborne, G.L.1
-
22
-
-
0030034717
-
Central mediation of the cannabinoid cue: Activity of a selective CB1 antagonist, SR 141716A
-
Pério A, Rinaldi-Carmona M, Maruani J, Barth F, Le Fur G, Soubrié P (1996) Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A. Behav Pharmacol 7:65-71
-
(1996)
Behav Pharmacol
, vol.7
, pp. 65-71
-
-
Pério, A.1
Rinaldi-Carmona, M.2
Maruani, J.3
Barth, F.4
Le Fur, G.5
Soubrié, P.6
-
23
-
-
0028129936
-
SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor
-
Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
-
(1994)
FEBS Lett
, vol.350
, pp. 240-244
-
-
Rinaldi-Carmona, M.1
Barth, F.2
Heaulme, M.3
Shire, D.4
Calandra, B.5
Congy, C.6
Martinez, S.7
Maruani, J.8
Néliat, G.9
Caput, D.10
Ferrara, P.11
Soubrié, P.12
Brelière, J.C.13
Le Fur, G.14
-
24
-
-
0028135046
-
Induction patterns of fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
-
Robertson GS, Matsumura H, Fibiger HC (1994) Induction patterns of fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271:1058-1066
-
(1994)
J Pharmacol Exp Ther
, vol.271
, pp. 1058-1066
-
-
Robertson, G.S.1
Matsumura, H.2
Fibiger, H.C.3
-
25
-
-
0030028250
-
Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
-
Santucci V, Storme JJ, Soubrié P, Le Fur G (1996) Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci 58:103-110
-
(1996)
Life Sci
, vol.58
, pp. 103-110
-
-
Santucci, V.1
Storme, J.J.2
Soubrié, P.3
Le Fur, G.4
-
27
-
-
0029965292
-
Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A
-
Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P (1996) Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem 271:6941-6946
-
(1996)
J Biol Chem
, vol.271
, pp. 6941-6946
-
-
Shire, D.1
Calandra, B.2
Delpech, M.3
Dumont, X.4
Kaghad, M.5
Le Fur, G.6
Caput, D.7
Ferrara, P.8
-
28
-
-
0015536067
-
Amphetamine psychosis: A "model" schizophrenia mediated by catecholamines
-
Snyder SH (1973) Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Am J Psychiatry 130:61-67
-
(1973)
Am J Psychiatry
, vol.130
, pp. 61-67
-
-
Snyder, S.H.1
-
29
-
-
0030870722
-
A second endogenous cannabinoid that modulates long-term potentiation
-
Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778
-
(1997)
Nature
, vol.388
, pp. 773-778
-
-
Stella, N.1
Schweitzer, P.2
Piomelli, D.3
-
31
-
-
0028811599
-
Inhibition of long-term potentiation in rat hippocampal slices by anandamide and Win 55212-2: Reversal by SR 141716A, a selective antagonist of CB1 cannabinoid receptors
-
Terranova JP, Michaud JC, Le Fur G, Soubrié P (1995) Inhibition of long-term potentiation in rat hippocampal slices by anandamide and Win 55212-2: reversal by SR 141716A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedeberg's Arch Pharmacol 352:576-579
-
(1995)
Naunyn-Schmiedeberg's Arch Pharmacol
, vol.352
, pp. 576-579
-
-
Terranova, J.P.1
Michaud, J.C.2
Le Fur, G.3
Soubrié, P.4
-
32
-
-
0030057082
-
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
-
Terranova JP, Storme JJ, Lafon N, Pério A, Rinaldi-Carmona M, Le Fur G, Soubrié P (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126:165-172
-
(1996)
Psychopharmacology
, vol.126
, pp. 165-172
-
-
Terranova, J.P.1
Storme, J.J.2
Lafon, N.3
Pério, A.4
Rinaldi-Carmona, M.5
Le Fur, G.6
Soubrié, P.7
-
34
-
-
0029643521
-
9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist
-
9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur J Pharmacol 280:R13-R15
-
(1995)
Eur J Pharmacol
, vol.280
-
-
Tsou, K.1
Patrick, S.L.2
Walker, J.M.3
|